Print Page   |   Contact Us   |   Sign In   |   Join
Millendo Therapeutics
Profile Pages More
Last updated: 4/4/2017
Millendo Therapeutics
Bioscience Company
Organization Information
Millendo Therapeutics
301 N Main St
Ann Arbor
48104-1296  United States
 [ Map ]
Visit Website »
CEO / President
  Millendo Therapeutics is focused on developing novel treatments for endocrine diseases caused by hormone dysregulation. Our mission is to build a leading endocrine company that creates distinct and transformative treatments for a wide range of diseases where there is a significant unmet medical need. We are advancing two product candidates in five indications: MLE4901, designed to address Polycystic Ovary Syndrome (PCOS) and Vasomotor Symptoms (VMS), and ATR-101 for the treatment of Classic Congenital Adrenal Hyperplasia (CAH), Endogenous Cushing’s Syndrome (CS), and Adrenocortical Carcinoma (ACC).
  R&D/Testing Labs - Biotechnology/Pharma
  Pharma & Therapeutics - Rx & Consumer Health
  541711 - R&D; biotechnology
Contact Information
Creating Value
by delivering business-critical resources & bottom line savings
Building Networks
by connecting Michigan's bio-industry one member at a time
Growing Talent
by creating opportunities that develop people & build organizations
Membership Software Powered by YourMembership  ::  Legal